Thus, reduced catabolism resulting from microvascular damage in the kidney leads to a gradual elevation in the plasma RBP4 concentration and hence to higher levels in subjects with DN than in T2DM patients without DN. The gene discussed is RBP4; the disease is type 2 diabetes mellitus.